MATTHEW BAYLON: Open Payments
NPI 1760020077 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,425 in 201 payments from 27 companies in 2025. Trend: 2023 $2,221 · 2024 $2,646 · 2025 $4,425
Food & beverage: $4,275Consulting: $94Education: $56
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $646 |
| GlaxoSmithKline, LLC. | 37 | $565 |
| GENZYME CORPORATION | 25 | $503 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $384 |
| Organon LLC | 9 | $299 |
| CSL Behring | 7 | $216 |
| Octapharma USA, Inc. | 4 | $194 |
| Novartis Pharmaceuticals Corporation | 9 | $172 |
| Regeneron Healthcare Solutions, Inc. | 7 | $155 |
| Amgen Inc. | 11 | $142 |
Products named: DUPIXENT, NUCALA, AIRSUPRA, VTAMA, TEZSPIRE, CUVITRU, AYVAKIT, Xembify.
Industry payments across AZ — which companies pay providers there.
